Canadian Manufacturing

medicine

Advertisement

Stories continue below

Financing Manufacturing Operations Regulation Sales & Marketing

June 21, 2023
Groupe LSL Pharma announces increased production capacity

Manufacturing Research & Development Supply Chain

August 25, 2022
Liminal BioSciences terminates legacy CDMO contract

Manufacturing Research & Development Technology / IIoT

March 18, 2022
Using artificial intelligence in health sciences education requires interdisciplinary collaboration and risk assessment

Environment Manufacturing

March 3, 2022
Future infectious diseases: Recent history shows we can never again be complacent about pathogens

Manufacturing Supply Chain

January 25, 2022
Lower drug prices are a priority for Canadians, but not for the federal government

Human Resources Manufacturing Research & Development Women in Manufacturing

January 4, 2022
Avicanna appoints Eileen McCormack to board of directors

Manufacturing Regulation Research & Development

January 3, 2022
How will pandemic end? Omicron clouds forecasts for endgame

Financing Manufacturing Operations Research & Development Risk & Compliance

October 28, 2021
MilliporeSigma announces increased capacity to advance antibody-drug conjugate therapies

Manufacturing Regulation Research & Development

June 16, 2021
FDA approval of controversial Alzheimer’s drug could delay discovery of more promising treatments

Environment Manufacturing Research & Development Risk & Compliance Sustainability

June 15, 2021
Toxic, long-lasting contaminants detected in people living in northern Canada

Manufacturing Operations Research & Development

June 14, 2021
McGill University Health Centre begins phase III trial for its COVID-19 anti-inflammatory drug